John Truesdell has extensive life science and leadership experience, built from 14 years in commercial, business development and lifecycle management positions within the medical device and diagnostics industries. Prior to SeQure Dx, John held key roles at Foundation Medicine (FMI), including Tissue Diagnostic Lifecycle Leader and Head of Marketing, leading the preparation and launch of FoundationOne CDx. He was an instrumental contributor to FMI’s initial companion diagnostic strategy and early biopharma partnerships. John is also a US Navy SEAL combat veteran with over a decade of experience leading teams in austere locations throughout the world.
John Truesdell
CBO